A Randomised, Controlled, Open Label, Multicentre, Multinational, Treat-to-target Trial Investigating the Efficacy and Safety of Intensification With Addition of Bolus Insulin Aspart in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin With or Without Oral Anti-diabetic Drugs: Step-wise Addition Versus Complete Basal-bolus Therapy.
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2017
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Full-STEP
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History